+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Twenty-Five-Year Mortality Follow-Up in the Belgian Bank Study

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          Two cohorts of male bank employees aged 40-59 at baseline and free of coronary heart disease were pooled and followed during 25 years for all-cause and coronary mortality. The vital status was known for all 1,227 subjects, but in both banks, 8% of all deaths occurred without any clue to a possible cause. All-cause and coronary mortality were 36.9 and 10.5 per 100 subjects, respectively. In bivariate analysis (adjusting for age), systolic blood pressure, diastolic blood pressure, serum cholesterol and cigarette smoking predicted all-cause mortality. The same variables predicted coronary mortality. Body mass index was neither a predictor of all-cause nor of coronary mortality. In multivariate analysis, age, systolic blood pressure and cigarette smoking predicted independently all-cause mortality whereas the same variables and serum cholesterol predicted coronary mortality. For coronary mortality, the odds ratio (OR) of systolic blood pressure ≧ 160 against < 140 mm Hg was 2.68 (95% confidence interval, CI: 1.41-5.08). The OR for subjects with baseline serum cholesterol ≧260 versus < 260 mg/dl was 1.68 (95% CI: 1.31-2.51). The OR for cigarette smokers versus never smokers was 2.54 (95% CI: 1.39-4.64). Age-adjusted relative risk for all-cause mortality for subjects in the highest versus the lowest quintile of a multiple logistic function was 1.72 whereas for coronary mortality the relative risk was 4.94. These results confirm the long-term predictive power of the three major modifiable coronary risk factors when measured once in middle-aged male subjects.

          Related collections

          Author and article information

          S. Karger AG
          14 November 2008
          : 82
          : 2-3
          : 153-171
          Laboratory of Epidemiology and Social Medicine, School of Public Health, Brussels Free University, Brussels, Belgium
          175865 Cardiology 1993;82:153–171
          © 1993 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 19


          Comment on this article